|
The North American Neuromodulation Society (NANS) has submitted formal comments to the Centers for Medicare & Medicaid Services (CMS) regarding the proposed revisions to the 2026 Medicare Physician Fee Schedule (MPFS).
0 Comments
Last week, CMS issued the final rule for the Medicare Hospital Inpatient Prospective Payment System (IPPS) for fiscal year (FY) 2026.
NANS, joined by 11 leading medical societies, has sent a letter to Aetna urging the insurer to align its Medicare Advantage coverage policies for Peripheral Nerve Stimulation (PNS) with the existing National Coverage Determination (NCD 160.7).
The Drug Enforcement Administration (DEA) is warning medical professionals about a rise in scams involving fake letters and phone calls. Scammers are impersonating DEA agents and falsely claiming that practitioners are under investigation—often in an attempt to steal personal or sensitive information.
Physicians may get a 2.5% Medicare payment increase in 2026, thanks to new language added to the Senate’s budget legislation—an important win for clinicians after sustained advocacy efforts.
The North American Neuromodulation Society (NANS), alongside more than 70 leading medical organizations, has signed a joint letter urging the Senate to include a key Medicare payment provision from the House-passed One Big Beautiful Bill Act (H.R. 1) in its upcoming legislative package.
The North American Neuromodulation Society (NANS), alongside several leading medical societies, has submitted a formal letter to Carelon Medical Benefits Management in response to its recent policy denying coverage for spinal cord stimulation (SCS) in patients with non-surgical low back pain.
On Tuesday, June 10, NANS filed comments to CMS on the proposed rule setting forth proposed changes for the Medicare Hospital Inpatient Prospective Payment System (IPPS) for fiscal year (FY) 2026.
NANS spearheaded a letter to Humana executives after members expressed serious concerns regarding ongoing prior authorization delays and denials for Peripheral Nerve Stimulation (PNS) treatments for Humana Medicare Advantage beneficiaries.
The AMA strongly supports section 44304 of the Medicare proposal that provides a positive payment update of 75% of the Medicare Economic Index (MEI) for 2026.
|
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
January 2026
Categories |
RSS Feed